Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,365 HKD | 0,00 % | 0,00 % | -20,65 % |
Resumen de negocios
Número de empleados: 347
Ventas por actividad
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Monoclonal Antibody Drugs
100,0
%
| 65 | 100,0 % | 96 | 100,0 % | +48,11 % |
Ventas por región
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 65 | 100,0 % | 96 | 100,0 % | +48,11 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Hao Wang
CEO | Chief Executive Officer | 55 | 20/07/18 |
Yun Feng Li
DFI | Director of Finance/CFO | 47 | 20/07/18 |
Tao Jing
BRD | Director/Board Member | 51 | 03/08/18 |
Zhuge Wenhui
SAM | Sales & Marketing | - | 01/08/18 |
Ho Yin Tsang
SEC | Corporate Secretary | 38 | 31/05/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Shu Ge Jiao
CHM | Chairman | 58 | 20/07/18 |
Ho Ming Leung
BRD | Director/Board Member | 41 | 17/06/22 |
Wei Zhu Qian
FOU | Founder | 48 | 04/02/15 |
Hao Wang
CEO | Chief Executive Officer | 55 | 20/07/18 |
Yun Feng Li
DFI | Director of Finance/CFO | 47 | 20/07/18 |
Liang Zhong Guo
BRD | Director/Board Member | 58 | 10/08/18 |
Yan Yun Zhang
BRD | Director/Board Member | 68 | 10/08/18 |
Tao Jing
BRD | Director/Board Member | 51 | 03/08/18 |
Sheng Hou
BRD | Director/Board Member | 47 | 28/11 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 4 124 080 000 | 941 260 140 ( 22,82 %) | 0 | 22,82 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-20,65 % | 193 M | |
+15,19 % | 121 mil M | |
+19,91 % | 114 mil M | |
-19,80 % | 20,43 mil M | |
-16,36 % | 16,55 mil M | |
-13,45 % | 16,45 mil M | |
-44,35 % | 15,59 mil M | |
+66,67 % | 15,19 mil M | |
+2,13 % | 13,54 mil M | |
+119,39 % | 10,96 mil M |
- Bolsa de valores
- Acciones
- Acción 2181
- Empresa Mabpharm Limited